Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrizia Russo

Showing results (21-30 of 92) with videos related to

Pageof 10
Sort By:
International Journal of Cancer|July 13, 2002
RPR-115135, a farnesyltransferase inhibitor, increases 5-FU- cytotoxicity in ten human colon cancer cell lines: role of p53Patrizia Russo, Davide Malacarne, Carla Falugi, et al.
Current Drug Targets|February 4, 2012
The sea urchin, Paracentrotus lividus, as a model to investigate the onset of molecules immunologically related to the α-7 subunit of nicotinic receptors during embryonic and larval developmentMaria Grazia Aluigi, Alberto Diaspro, Paola Ramoino, et al.
Current Pharmaceutical Design|March 20, 2014
Alpha9 alpha10 nicotinic acetylcholine receptors as target for the treatment of chronic painAlessandra Del Bufalo, Alfredo Cesario, Gianluca Salinaro, et al.
Current Pharmaceutical Design|March 20, 2014
Beyond acetylcholinesterase inhibitors for treating Alzheimer's disease: α7-nAChR agonists in human clinical trialsPatrizia Russo, Alessandra Del Bufalo, Alessandra Frustaci, et al.
Current Medicinal Chemistry. Anti-Cancer Agents|December 8, 2004
Role of the non-neuronal human cholinergic system in lung cancer and mesothelioma: possibility of new therapeutic strategiesSonya Trombino, Alessandra Bisio, Alessia Catassi, et al.
Marine Drugs|March 25, 2017
Metabolic Disorder in Chronic Obstructive Pulmonary Disease (COPD) Patients: Towards a Personalized Approach Using Marine Drug DerivativesPalma Lamonaca, Giulia Prinzi, Aliaksei Kisialiou, et al.
Marine Drugs|September 6, 2018
Cognitive Impairment in Chronic Obstructive Pulmonary Disease (COPD): Possible Utility of Marine Bioactive CompoundsGiulia Prinzi, Alessia Santoro, Palma Lamonaca, et al.
Anti-Cancer Agents in Medicinal Chemistry|July 17, 2007
Nicotine, lung and cancerAlessia Grozio, Alessia Catassi, Zita Cavalieri, et al.
Marine Drugs|December 30, 2015
New Drugs from Marine Organisms in Alzheimer's DiseasePatrizia Russo, Aliaksei Kisialiou, Palma Lamonaca, et al.
Antioxidants (Basel, Switzerland)|October 29, 2025
Oxidative Stress and DNA Damage Biomarkers in Heart Failure: A Systematic Review and Meta-AnalysisFrancesca Milani, Annamaria Porreca, Giuseppe Rosano, et al.
Pageof 10

Showing results (21-30 of 92) with videos related to

Sort By:
Pageof 10
International Journal of Cancer|July 13, 2002
RPR-115135, a farnesyltransferase inhibitor, increases 5-FU- cytotoxicity in ten human colon cancer cell lines: role of p53Patrizia Russo, Davide Malacarne, Carla Falugi, et al.
Current Drug Targets|February 4, 2012
The sea urchin, Paracentrotus lividus, as a model to investigate the onset of molecules immunologically related to the α-7 subunit of nicotinic receptors during embryonic and larval developmentMaria Grazia Aluigi, Alberto Diaspro, Paola Ramoino, et al.
Current Pharmaceutical Design|March 20, 2014
Alpha9 alpha10 nicotinic acetylcholine receptors as target for the treatment of chronic painAlessandra Del Bufalo, Alfredo Cesario, Gianluca Salinaro, et al.
Current Pharmaceutical Design|March 20, 2014
Beyond acetylcholinesterase inhibitors for treating Alzheimer's disease: α7-nAChR agonists in human clinical trialsPatrizia Russo, Alessandra Del Bufalo, Alessandra Frustaci, et al.
Current Medicinal Chemistry. Anti-Cancer Agents|December 8, 2004
Role of the non-neuronal human cholinergic system in lung cancer and mesothelioma: possibility of new therapeutic strategiesSonya Trombino, Alessandra Bisio, Alessia Catassi, et al.
Marine Drugs|March 25, 2017
Metabolic Disorder in Chronic Obstructive Pulmonary Disease (COPD) Patients: Towards a Personalized Approach Using Marine Drug DerivativesPalma Lamonaca, Giulia Prinzi, Aliaksei Kisialiou, et al.
Marine Drugs|September 6, 2018
Cognitive Impairment in Chronic Obstructive Pulmonary Disease (COPD): Possible Utility of Marine Bioactive CompoundsGiulia Prinzi, Alessia Santoro, Palma Lamonaca, et al.
Anti-Cancer Agents in Medicinal Chemistry|July 17, 2007
Nicotine, lung and cancerAlessia Grozio, Alessia Catassi, Zita Cavalieri, et al.
Marine Drugs|December 30, 2015
New Drugs from Marine Organisms in Alzheimer's DiseasePatrizia Russo, Aliaksei Kisialiou, Palma Lamonaca, et al.
Antioxidants (Basel, Switzerland)|October 29, 2025
Oxidative Stress and DNA Damage Biomarkers in Heart Failure: A Systematic Review and Meta-AnalysisFrancesca Milani, Annamaria Porreca, Giuseppe Rosano, et al.
Pageof 10